Joseph Michael Fitzgerald is EVP & Group Pres, Cardiology of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 148,118 shares of BSX, which is worth approximately $13.2 Million. The most recent transaction as insider was on Feb 21, 2023, when has been sold 1,923 shares (Common Stock) at a price of $46.23 per share, resulting in proceeds of $88,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 148K
16.01% 3M change
25.19% 12M change
Total Value Held $13.2 Million

Joseph Michael Fitzgerald Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 21 2023
SELL
Payment of exercise price or tax liability
$88,900 $46.23 p/Share
1,923 Reduced 0.87%
220,277 Common Stock
Feb 21 2023
BUY
Exercise of conversion of derivative security
-
3,895 Added 1.72%
222,200 Common Stock
Feb 18 2023
SELL
Payment of exercise price or tax liability
$85,121 $46.54 p/Share
1,829 Reduced 0.83%
218,305 Common Stock
Feb 18 2023
BUY
Exercise of conversion of derivative security
-
3,706 Added 1.66%
220,134 Common Stock
Feb 17 2023
SELL
Payment of exercise price or tax liability
$95,686 $46.54 p/Share
2,056 Reduced 0.94%
216,428 Common Stock
Feb 17 2023
BUY
Exercise of conversion of derivative security
-
4,166 Added 1.87%
218,484 Common Stock
Feb 16 2023
SELL
Payment of exercise price or tax liability
$83,942 $46.48 p/Share
1,806 Reduced 0.84%
214,318 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
3,960 Added 1.8%
216,124 Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$117,657 $47.29 p/Share
2,488 Reduced 1.16%
211,954 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
4,615 Added 2.11%
214,442 Common Stock
Feb 13 2023
SELL
Bona fide gift
-
11,000 Reduced 4.98%
209,827 Common Stock
Feb 09 2023
SELL
Bona fide gift
-
2,520 Reduced 1.13%
220,827 Common Stock
Jan 01 2023
SELL
Payment of exercise price or tax liability
$308,065 $46.27 p/Share
6,658 Reduced 2.89%
223,347 Common Stock
Jan 01 2023
BUY
Exercise of conversion of derivative security
-
13,134 Added 5.4%
230,005 Common Stock
Dec 13 2022
SELL
Open market or private sale
$3,787,233 $47.78 p/Share
79,264 Reduced 26.77%
216,871 Common Stock
Dec 13 2022
BUY
Exercise of conversion of derivative security
$585,760 $7.39 p/Share
79,264 Added 21.11%
296,135 Common Stock
Jul 29 2022
SELL
Bona fide gift
-
1,000 Reduced 0.46%
216,871 Common Stock
Mar 03 2022
SELL
Payment of exercise price or tax liability
$78,205 $43.96 p/Share
1,779 Reduced 0.81%
217,871 Common Stock
Mar 03 2022
BUY
Exercise of conversion of derivative security
-
3,603 Added 1.61%
219,650 Common Stock
Feb 21 2022
SELL
Payment of exercise price or tax liability
$81,824 $42.55 p/Share
1,923 Reduced 0.88%
216,047 Common Stock
Feb 21 2022
BUY
Exercise of conversion of derivative security
-
3,895 Added 1.76%
217,970 Common Stock
Feb 18 2022
SELL
Payment of exercise price or tax liability
$77,824 $42.55 p/Share
1,829 Reduced 0.85%
214,075 Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
-
3,706 Added 1.69%
215,904 Common Stock
Feb 17 2022
SELL
Payment of exercise price or tax liability
$88,058 $42.83 p/Share
2,056 Reduced 0.96%
212,198 Common Stock
Feb 17 2022
BUY
Exercise of conversion of derivative security
-
4,166 Added 1.91%
214,254 Common Stock
JMF

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology
Marlborough, MA

Track Institutional and Insider Activities on BSX

Follow BOSTON SCIENTIFIC CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX